Detalles de la búsqueda
1.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Lancet Oncol
; 20(2): 267-281, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579763
2.
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 18(9): 1192-1201, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28760403
3.
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Lancet Oncol
; 17(6): 727-737, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155740
4.
Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: a cluster randomised controlled trial.
BMC Cancer
; 16: 637, 2016 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27530156
5.
Tolerability and outcomes of curative radiotherapy in patients aged 85 or more years.
Med J Aust
; 202(3): 153-5, 2015 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25669479
6.
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Lancet Oncol
; 15(10): 1076-89, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25130995
7.
Impact of androgen suppression and zoledronic acid on bone mineral density and fractures in the Trans-Tasman Radiation Oncology Group (TROG) 03.04 Randomised Androgen Deprivation and Radiotherapy (RADAR) randomized controlled trial for locally advanced prostate cancer.
BJU Int
; 114(3): 344-53, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24512527
8.
Ten-year results of quality assurance in radiotherapy chart round.
BMC Health Serv Res
; 13: 148, 2013 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23617328
9.
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Lancet Oncol
; 13(12): 1260-70, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23151431
10.
The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
Med Phys
; 50(1): 20-29, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36354288
11.
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
Lancet Oncol
; 12(5): 451-9, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21440505
12.
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
Cancer Imaging
; 22(1): 58, 2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209121
13.
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer.
Clin Transl Radiat Oncol
; 30: 65-70, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34401535
14.
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.
Radiother Oncol
; 151: 234-241, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32828839
15.
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial.
Int J Radiat Oncol Biol Phys
; 106(4): 693-702, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092343
16.
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial.
Int J Radiat Oncol Biol Phys
; 107(3): 530-538, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234553
17.
Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial.
Radiother Oncol
; 90(3): 400-7, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18952309
18.
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial.
Lancet Oncol
; 9(11): 1058-68, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18929505
19.
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial.
Med Phys
; 46(11): 4725-4737, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446633
20.
TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol.
BMJ Open
; 9(8): e030731, 2019 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31434782